Bioavailability of Fish Oils: Emulsified Versus Capsular Triglyceride
NCT ID: NCT01488747
Last Updated: 2018-08-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
19 participants
INTERVENTIONAL
2011-11-30
2016-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The primary endpoints to be evaluated include the fatty acid composition of plasma lipids before and after consumption of a single dose of emulsified triglyceride based fish oil and triglyceride of similar n-3 compositions in capsule form. The investigators will measure changes in plasma phospholipid, and chylomicron fatty acids.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Bioavailability of Omega-3 Fatty Acids From Fish Oil Supplements
NCT06665464
Bioavailability Study of Long Chain Omega-3 Fatty Acids From a Gastric Stable Emulsion
NCT01061554
Effect of Fish Oil on Plasma Triglycerides in Adults
NCT00804427
Comparing the Pharmacological Profile of Formulations Containing Omega 3 Fatty Acids
NCT05394701
Cardiometabolic Benefits of Omega-3 Polyunsaturated Fatty Acids
NCT03378232
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Coromega Omega-3 Squeeze
5.03 g
Coromega Omega-3 Squeeze
660 mg EPA, 434 mg DHA
Coromega Nectar
12.22 g
Coromega Nectar
660 mg EPA, 436 mg DHA
Barleans Swirl
17.45 g
Barleans Swirl
660 mg EPA, 660 mg DHA
Nordic Omega-3 Softgel
4 softgels
Nordic Omega-3 Softgel
660 mg EPA, 440 mg DHA
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Coromega Omega-3 Squeeze
660 mg EPA, 434 mg DHA
Coromega Nectar
660 mg EPA, 436 mg DHA
Barleans Swirl
660 mg EPA, 660 mg DHA
Nordic Omega-3 Softgel
660 mg EPA, 440 mg DHA
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Body mass index between 22 and 32 kg/m2.
3. Medical history (interview) demonstrating good health.
4. Nonsmoker.
5. Consumption of a typical American diet with no unusual dietary habits.
6. Willingness to comply with the study protocol.
7. Low reported n-3 intake (\<100 mg/d) on the Omega-3 Checklist
Exclusion Criteria
2. Consumption of essential fatty acid supplements within the past 6 months.
3. Use of lipid lowering drugs.
4. Fish consumption greater than 1 fish meal per week
18 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
USDA Grand Forks Human Nutrition Research Center
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Susan Raatz, PhD, RD
Role: PRINCIPAL_INVESTIGATOR
USDA Grand Forks Human Nutrition Research Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
USDA Grand Forks Human Nutrition Research Center
Grand Forks, North Dakota, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Raatz SK, Redmon JB, Wimmergren N, Donadio JV, Bibus DM. Enhanced absorption of n-3 fatty acids from emulsified compared with encapsulated fish oil. J Am Diet Assoc. 2009 Jun;109(6):1076-81. doi: 10.1016/j.jada.2009.03.006.
Related Links
Access external resources that provide additional context or updates about the study.
USDA Grand Forks Human Nutrition Research Center
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GFHNRC023
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.